{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:49:01Z","timestamp":1778356141463,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.schres.2012.03.017","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T06:31:47Z","timestamp":1341556307000},"page":"159-168","source":"Crossref","is-referenced-by-count":160,"title":["Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials"],"prefix":"10.1016","volume":"140","author":[{"given":"Jacqueline","family":"Caemmerer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.schres.2012.03.017_bb0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.03.017_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/appi.ps.54.4.565","article-title":"The impact of weight gain on quality of life among persons with schizophrenia","volume":"54","author":"Allison","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2012.03.017_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4088\/JCP.v67n0812","article-title":"Attenuation of antipsychotic-inducted weight gain with early behavioral intervention in drug-na\u00efve first-episode psychosis patients: a randomized controlled trial","volume":"67","author":"Alvarez-Jimenez","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.bp.107.042853","article-title":"Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials","volume":"193","author":"Alvarez-Jimenez","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2009.10.012","article-title":"Prevention of antipsychotic-induced weight gain with early behavioral intervention in first episode psychosis: 2-year results if a randomized controlled trial","volume":"116","author":"Alvarez-Jimenez","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2012.03.017_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","author":"American Diabetes Association","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/01612840590959551","article-title":"Effects of exercise on mental and physical health parameters of persons with schizophrenia","volume":"26","author":"Beebe","year":"2005","journal-title":"Issues Ment. Health Nurs."},{"key":"10.1016\/j.schres.2012.03.017_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v66n0208","article-title":"Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder","volume":"66","author":"Brar","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0050","unstructured":"Cordes, J., Thunker, J., Regenbrecht, J.Z., Correll, C.U., Schmidt-Kraepelin, C., Lange-Asschenfeldt, C., Agelink, M.W., Kahl, K.G., Gaebel, W., Klimke, A., Hauner, H., in press. Can an early weight management program (WMP) prevent olanzapine-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four and 48-week results from a 6-month randomized trial. World J. Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.schres.2012.03.017_bb9000","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.schres.2012.03.017_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.schres.2012.03.017_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4088\/JCP.11r07064","article-title":"Developments in pediatric psychopharmacology: focus on stimulants, antidepressants and antipsychotics","volume":"72","author":"Correll","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.03.017_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.schres.2012.03.017_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.03.017_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.schres.2012.03.017_bb0080","first-page":"479","article-title":"Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial","volume":"39","author":"Evans","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"19","key":"10.1016\/j.schres.2012.03.017_bb0085","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2012.03.017_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1467-789X.2009.00570.x","article-title":"Efficacy of behavioural interventions in managing atypical antipsychotic weight gain","volume":"10","author":"Gabriele","year":"2009","journal-title":"Obes. Rev."},{"key":"10.1016\/j.schres.2012.03.017_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/oby.2006.291","article-title":"Relationship of metabolic risk factors and development of cardiovascular disease and diabetes","volume":"14","author":"Haffner","year":"2006","journal-title":"Obesity"},{"issue":"9618","key":"10.1016\/j.schres.2012.03.017_bb0100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2012.03.017_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2006.12.025","article-title":"Cognitive behavioural therapy for weight gain associated with antipsychotic drugs","author":"Khazaal","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.03.017_bb0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4088\/JCP.v67n0405","article-title":"Weight management program from treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial","volume":"67","author":"Kwon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.03.017_bb0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.mp.4002136","article-title":"How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials","volume":"14","author":"Leucht","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2012.03.017_bb0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.schres.2012.03.017_bb0125","first-page":"7","article-title":"The effects of an educational intervention on antipsychotic-induced weight gain","volume":"3","author":"Littrell","year":"2003","journal-title":"J. Nurs. Scholarsh."},{"key":"10.1016\/j.schres.2012.03.017_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/ern.10.85","article-title":"Management of antipsychotic-related weight gain","volume":"10","author":"Maayan","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"6","key":"10.1016\/j.schres.2012.03.017_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2011.0015","article-title":"Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents","volume":"21","author":"Maayan","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2012.03.017_bb0140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.schres.2012.03.017_bb0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2012.03.017_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-992148","article-title":"A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine","volume":"41","author":"Mauri","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2006.05.010","article-title":"A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial","volume":"86","author":"McKibbin","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.03.017_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2975\/31.3.2008.194.200","article-title":"Multi-modal weight control intervention for people with persistent mental disorders","volume":"31","author":"Melamed","year":"2008","journal-title":"Psychiatr. Rehabil. J."},{"issue":"12","key":"10.1016\/j.schres.2012.03.017_bb0165","first-page":"CD006629","article-title":"Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems","author":"Mukundan","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1\u20133","key":"10.1016\/j.schres.2012.03.017_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2010.02.001","article-title":"Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial","volume":"118","author":"Narula","year":"2010","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.schres.2012.03.017_bb0175","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2012.03.017_bb0180","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2012.03.017_bb0190","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1080\/00048670701689428","article-title":"Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme","volume":"41","author":"Poulin","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eatbeh.2005.08.003","article-title":"Weight change in treatment with olanzapine and a psychoeducational approach","volume":"7","author":"Scocco","year":"2006","journal-title":"Eat. Behav."},{"key":"10.1016\/j.schres.2012.03.017_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2975\/29.2005.122.127","article-title":"The role of a fitness intervention on people with serious psychiatric disabilities","volume":"29","author":"Skrinar","year":"2005","journal-title":"Psychiatr. Rehabil. J."},{"issue":"9","key":"10.1016\/j.schres.2012.03.017_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.2011.10111609","article-title":"A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)","volume":"168","author":"Stroup","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.03.017_bb0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2006.01.008","article-title":"A cognitive\/behavioral group intervention for weight loss in patients treated with atypical antipsychotics","volume":"83","author":"Weber","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.03.017_bb0215","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/appi.ps.58.4.544","article-title":"Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program","volume":"58","author":"Wu","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2012.03.017_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of anti-psychotic induced weight gain: a randomized controlled trial","author":"Wu","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2012.03.017_bb0225","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/JCP.0b013e31825cccd2","article-title":"Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with non-psychotic disorders or no psychiatric disorders: Results from a 12-month, real-world study","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T02:50:12Z","timestamp":1687575012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996412001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0920996412001703"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.03.017","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}